主讲人
发表于 2025-3-26 21:59:28
Joseph Krauß,Martin Berger,Walter Helmerst, the description of marketed ipilimumab formulation (Yervoy) is given along with the details of its clinical pharmacology. The mechanism of action of ipilimumab is then described followed by discussion on results from clinical trials that demonstrated the benefits of ipilimumab in treatment of pat
META
发表于 2025-3-27 02:24:19
http://reply.papertrans.cn/75/7478/747721/747721_32.png
半身雕像
发表于 2025-3-27 08:26:21
http://reply.papertrans.cn/75/7478/747721/747721_33.png
我不重要
发表于 2025-3-27 12:09:33
http://reply.papertrans.cn/75/7478/747721/747721_34.png
SPASM
发表于 2025-3-27 14:45:12
http://reply.papertrans.cn/75/7478/747721/747721_35.png
flavonoids
发表于 2025-3-27 20:00:12
http://reply.papertrans.cn/75/7478/747721/747721_36.png